dr. G.W.J. (Geert) Frederix Assistant Professor

Health Technology Assessment
Julius Center Research Program Methodology

Contact

gfreder2@umcutrecht.nl

Research programs

Child Health

Research Output

Research Output

Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: A multicenter prospective study (PLASTIC-study)

Brenkman HJF, Gertsen EC, Vegt E., van Hillegersberg R, van Berge Henegouwen M. I., Gisbertz S. S., Luyer M. D.P., Nieuwenhuijzen G. A.P., van Lanschot J. J.B., Lagarde S. M., de Steur W. O., Hartgrink H. H., Stoot J. H.M.B., Hulsewe K. W.E., Spillenaar Bilgen E. J., van Det M. J., Kouwenhoven E. A., van der Peet D. L., Daams F., van Sandick J. W., van Grieken N. C.T., Heisterkamp J., van Etten B., Haveman J. W., Pierie J. P., Jonker F., Thijssen A. Y., Belt E. J.T., van Duijvendijk P., Wassenaar E., van Laarhoven H. W.M., Wessels FJ, Haj Mohammad N, van Stel HF, Frederix GWJ, Siersema PD, Ruurda JP, 20 Apr 2018 In: BMC Cancer. 18

Is It Our Duty To Hunt for Pathogenic Mutations?

Wouters RHP, van Leeuwen RM, Frederix GWJ, Ausems MGEM, van Delden JJM, Voest EE, Bredenoord AL 1 Jan 2018 In: Trends in molecular medicine. 24, p. 3-6 4 p.

Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants

Blanken MO, Frederix GWJ, Nibbelke E.E., Koffijberg H, Sanders EAM, Rovers Maroeska , Bont LJ, Jan 2018 In: European Journal of Pediatrics. 177, p. 133-144 12 p.

Changing costs of metastatic non small cell lung cancer in the Netherlands

Keusters W R, de Weger Vincent A, Hövels A.M., Schellens Jan H M, Frederix GWJ Dec 2017 In: Lung cancer. 114, p. 56-61 6 p.

Health system productivity change in Zambia: A focus on the child health services

Achoki Tom, Kinfu Yohannes, Masiye Felix, Frederix GWJ, Hovels Anke, Leufkens Hubert G Feb 2017 In: Journal of public health policy. 38, p. 88-104 17 p.

Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The Netherlands

ter Heine Rob, Frederix GWJ, Geenen Joost W, Hövels Anke M, van Vulpen M, Kooistra Anko, de Klerk John Mh, Bloemendal HJ 2017 In: Journal of Comparative Effectiveness Research. 6, p. 575-581 7 p.

Unremarked or Unperformed?: Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer

de Boer Pieter T, Frederix GWJ, Feenstra Talitha L, Vemer Pepijn Sep 2016 In: PharmacoEconomics. 34, p. 833-845 13 p.

Patient monitoring: the hidden costs of treatment with antipsychotics

Nederlof Mariëtte, Frederix GWJ, Stoker Lennart J., van Solinge WW, Egberts ACG, Heerdink Eibert R. 1 Aug 2016 In: British Journal of Clinical Pharmacology. 82, p. 570-572 3 p.

Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions

Frederix GWJ, Haji Ali Afzali Hossein, Dasbach Erik J, Ward Robyn L Aug 2015 In: PharmacoEconomics. 33, p. 777-81 5 p.

Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium

Frederix GWJ, Severens J L, Hövels A M, van Hasselt J G C, Hooiveld M J J, Neven P, Raaijmakers J A M, Schellens J H M 2015 In: European Journal of Cancer Care. 24, p. 340-54 15 p.

All Research Output (14)

Contact

Research programs

Research Output

Deze website maakt gebruik van cookies